title: Mutations in the reverse transcriptase gene of HIV type 1 from subjects after stavudine-didanosine dual therapy.
authors.forename: L
authors.initials: L
authors.lastname: Monno
authors.forename: A
authors.initials: A
authors.lastname: Appice
authors.forename: T
authors.initials: T
authors.lastname: Scarabaggio
authors.forename: M
authors.initials: M
authors.lastname: Di Stefano
authors.forename: G
authors.initials: G
authors.lastname: Pastore
authors.forename: G
authors.initials: G
authors.lastname: Angarano
mesh_terms: D019380:Anti-HIV Agents / Q000627:therapeutic use*; D016049:Didanosine / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005814:Genes, Viral; D015658:HIV Infections / Q000188:drug therapy* / Q000821:virology; D054303:HIV Reverse Transcriptase / Q000235:genetics*; D015497:HIV-1 / Q000201:enzymology / Q000235:genetics; D006801:Humans; D009154:Mutation; D018894:Reverse Transcriptase Inhibitors / Q000627:therapeutic use; D017422:Sequence Analysis, DNA; D018119:Stavudine / Q000627:therapeutic use*
chemical_list: D019380:Anti-HIV Agents; D018894:Reverse Transcriptase Inhibitors; D018119:Stavudine; D054303:HIV Reverse Transcriptase; D016049:Didanosine